Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,757 | -8,774 | -38,816 | -28,560 | -18,430 |
| Depreciation Amortization | 1,056 | 520 | 2,043 | 1,884 | 1,183 |
| Income taxes - deferred | -631 | -271 | -1,443 | -1,563 | -962 |
| Accounts receivable | 194 | 227 | -102 | 174 | -116 |
| Accounts payable and accrued liabilities | 213 | 630 | -1,143 | -763 | -1,676 |
| Other Working Capital | 513 | 365 | -2,702 | -968 | -2,681 |
| Other Operating Activity | -2,394 | -1,703 | 9,975 | 7,036 | 6,738 |
| Operating Cash Flow | $-17,806 | $-9,006 | $-32,188 | $-22,760 | $-15,944 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,098 | -49 | -471 | -634 | -246 |
| Net Acquisitions | N/A | N/A | -12,075 | -12,075 | -12,075 |
| Purchase Of Investment | -905,000 | -193,000 | -371,449 | -60,200 | -1,200 |
| Sale Of Investment | 929,705 | 225,500 | 286,670 | 12,200 | 2,217 |
| Purchase Sale Intangibles | N/A | N/A | -2,157 | -1,157 | -1,157 |
| Other Investing Activity | 0 | 0 | -2,800 | -1,800 | -1,800 |
| Investing Cash Flow | $23,607 | $32,451 | $-100,125 | $-62,509 | $-13,104 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -18,067 | -18,067 | -18,067 |
| Common Stock Issued | 47 | N/A | 137,445 | 137,417 | 92,269 |
| Common Stock Repurchased | N/A | N/A | -1,081 | -1,081 | -1,074 |
| Other Financing Activity | -3,000 | -3,000 | -17,319 | -17,305 | -16,897 |
| Financing Cash Flow | $-2,953 | $-3,000 | $100,978 | $100,964 | $56,231 |
| Exchange Rate Effect | -80 | -104 | 74 | 7 | 4 |
| Beginning Cash Position | 9,823 | 9,823 | 41,084 | 41,084 | 41,084 |
| End Cash Position | 12,591 | 30,164 | 9,823 | 56,786 | 68,271 |
| Net Cash Flow | $2,768 | $20,341 | $-31,261 | $15,702 | $27,187 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,806 | -9,006 | -32,188 | -22,760 | -15,944 |
| Capital Expenditure | -1,098 | -49 | -471 | -634 | -246 |
| Free Cash Flow | -18,904 | -9,055 | -32,659 | -23,394 | -16,190 |